Q3 2022 PDS Biotechnology Corp Earnings Call Transcript
Greetings. Welcome to PDS Biotech's Third Quarter 2020 Earnings Conference Call and Webcast. (Operator Instructions) At this time, I'll hand the conference over to Gabrielle DeGravina, CG Capital. Gabby, you may now begin.
Good morning, and welcome to PDS Biotechnology's Third Quarter 2022 Earnings Conference Call and Audio Webcast. With me today from the company are Dr. Frank Bedu-Addo, Chief Executive Officer; Dr. Lauren B. Wood, Chief Medical Officer; and Matt Hill, Chief Financial Officer. Earlier this morning, PDS Biotech issued a press release announcing financial results for the quarter ended September 30th, 2022. We encourage everyone to read the press release as well as PDS Biotech report on Form 10-Q, which will be filed with the SEC shortly. The company's press release is available on PDS' website at pdsbiotech.com. In addition, this conference call is being webcast and will be archived on the company website for future reference.
Before we begin, we need to remind everyone
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |